Home/GT Apeiron/Mingxi Li, PhD

ML

Mingxi Li, PhD

Chief Executive Officer

Therapeutic Areas

GT Apeiron Pipeline

Drug	Indication	Phase
GTA182	MTAP-Deleted Advanced Non-Small Cell Lung Cancer	Phase 1

Leadership Team at GT Apeiron

Fred Aswad, JD, PhD

Chief Scientific Officer

Xiaohui Gu, PhD

Senior Vice President of Chemistry

Jim Joseph, PhD

Vice President of Biology

Minghua Wang, PhD

Director of AIDD

View full GT Apeiron profile